Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Heron Therapeutics, Inc.(HRTX) | 6,986,744 | 8,753,290 | +1,766,546 | $14.46M | $11.03M | 10.36% | -$3.43M |
| Cidara Therapeutics Inc | 100,000 | 108,404 | +8,404 | $4.87M | $10.38M | 9.75% | +$5.51M |
| Protara Therapeutics, Inc.(TARA) | 2,139,000 | 2,139,000 | 0 | $6.48M | $9.30M | 8.74% | +$2.82M |
| Rezolute, Inc.(RZLT) | 750,000 | 750,000 | 0 | $3.35M | $7.05M | 6.62% | +$3.71M |
| Praxis Precision Medicines, Inc.(PRAX) | 149,334 | 132,805 | -16,529 | $6.28M | $7.04M | 6.61% | +$759.2K |
| Mineralys Therapeutics, Inc.(MLYS) | 174,600 | 175,600 | +1,000 | $2.36M | $6.66M | 6.25% | +$4.30M |
| Jasper Therapeutics, Inc.(JSPR) | 1,433,828 | 2,668,395 | +1,234,567 | $7.96M | $6.21M | 5.83% | -$1.75M |
| ABIVAX Société AnonymeADS(ABVX) | 0 | 64,389 | +64,389 | $0 | $5.47M | 5.13% | +$5.47M |
| InspireMD, Inc.(NSPR) | 904,029 | 2,143,698 | +1,239,669 | $2.05M | $5.17M | 4.85% | +$3.11M |
| Zooz Pwr LtdSHARE SHARE | 0 | 2,000,000 | +2,000,000 | $0 | $4.28M | 4.02% | +$4.28M |
| Alumis Inc | 1,620,846 | 946,683 | -674,163 | $4.86M | $3.78M | 3.55% | -$1.09M |
| Lantheus Holdings, Inc.(LNTH) | 0 | 73,545 | +73,545 | $0 | $3.77M | 3.54% | +$3.77M |
| Avalo Therapeutics, Inc.(AVTX) | 154,972 | 263,642 | +108,670 | $773.3K | $3.35M | 3.15% | +$2.58M |
| Sutro Biopharma, Inc.(STRO) | 3,060,000 | 3,120,000 | +60,000 | $2.18M | $2.71M | 2.54% | +$524.9K |
| Eupraxia Pharmaceuticals Inc.(EPRX) | 0 | 352,000 | +352,000 | $0 | $2.08M | 1.95% | +$2.08M |
| Rapt Therapeutics Inc | 0 | 79,977 | +79,977 | $0 | $2.06M | 1.94% | +$2.06M |
| Syndax Pharmaceuticals, Inc.(SNDX) | 0 | 130,000 | +130,000 | $0 | $2.00M | 1.88% | +$2.00M |
| Trevi Therapeutics, Inc.(TRVI) | 0 | 205,000 | +205,000 | $0 | $1.88M | 1.76% | +$1.88M |
| uniQure N.V.SHS(QURE) | 0 | 32,000 | +32,000 | $0 | $1.87M | 1.75% | +$1.87M |
| Viridian Therapeutics, Inc.(VRDN) | 86,500 | 86,500 | 0 | $1.21M | $1.87M | 1.75% | +$657.4K |
| Edesa Biotech, Inc.(EDSA) | 687,500 | 687,500 | 0 | $1.40M | $1.70M | 1.60% | +$302.5K |
| TELA Bio, Inc.(TELA) | 747,410 | 747,410 | 0 | $1.45M | $1.11M | 1.05% | -$336.3K |
| Eledon Pharmaceuticals, Inc.(ELDN) | 338,973 | 346,973 | +8,000 | $918.6K | $898.7K | 0.84% | -$20.0K |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 59,000 | 61,000 | +2,000 | $407.1K | $771.6K | 0.72% | +$364.6K |
| Tenax Therapeutics, Inc.(TENX) | 83,333 | 83,333 | 0 | $480.0K | $634.2K | 0.60% | +$154.2K |
| Tourmaline Bio Inc | 393,889 | 5,800 | -388,089 | $6.30M | $277.4K | 0.26% | -$6.02M |
| CytomX Therapeutics, Inc.(CTMX) | 75,000 | 80,000 | +5,000 | $170.3K | $255.2K | 0.24% | +$85.0K |
| Protagonist Therapeutics Inc | 3,700 | 3,700 | 0 | $204.5K | $245.8K | 0.23% | +$41.3K |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | 0 | 6,500 | +6,500 | $0 | $224.2K | 0.21% | +$224.2K |
| Ovid Therapeutics Inc.(OVID) | 160,000 | 160,000 | 0 | $52.8K | $208.0K | 0.20% | +$155.2K |
| Gossamer Bio, Inc.(GOSS) | 75,000 | 70,000 | -5,000 | $92.3K | $184.1K | 0.17% | +$91.8K |
| Alector Inc | 55,000 | 55,000 | 0 | $77.0K | $162.8K | 0.15% | +$85.8K |
| Design Therapeutics, Inc.(DSGN) | 20,000 | 20,000 | 0 | $67.4K | $150.6K | 0.14% | +$83.2K |
| Terns Pharmaceuticals Inc | 20,000 | 20,000 | 0 | $74.6K | $150.2K | 0.14% | +$75.6K |
| Nurix Therapeutics, Inc.(NRIX) | 10,000 | 16,000 | +6,000 | $113.9K | $147.8K | 0.14% | +$33.9K |
| Erasca, Inc.(ERAS) | 65,000 | 65,000 | 0 | $82.5K | $141.7K | 0.13% | +$59.1K |
| Ventyx Biosciences Inc | 40,000 | 40,000 | 0 | $85.6K | $124.4K | 0.12% | +$38.8K |
| Pyxis Oncology, Inc.(PYXS) | 40,000 | 55,000 | +15,000 | $44.0K | $122.1K | 0.11% | +$78.1K |
| Immunome, Inc.(IMNM) | 0 | 10,000 | +10,000 | $0 | $117.1K | 0.11% | +$117.1K |
| Precision BioSciences, Inc.(DTIL) | 0 | 20,000 | +20,000 | $0 | $110.4K | 0.10% | +$110.4K |
| Wave Life Sciences, Inc.SHS(WVE) | 15,000 | 15,000 | 0 | $97.5K | $109.8K | 0.10% | +$12.3K |
| Geron Corporation(GERN) | 70,000 | 80,000 | +10,000 | $98.7K | $109.6K | 0.10% | +$10.9K |
| Larimar Therapeutics, Inc.(LRMR) | 33,000 | 33,000 | 0 | $95.4K | $106.6K | 0.10% | +$11.2K |
| Context Therapeutics Inc.(CNTX) | 100,000 | 100,000 | 0 | $65.5K | $96.9K | 0.09% | +$31.4K |
| Proqr Thrapeutics N VSHS EURO SHS EURO | 45,000 | 45,000 | 0 | $91.8K | $95.8K | 0.09% | +$4.0K |
| Replimune Group, Inc.(REPL) | 183,083 | 20,000 | -163,083 | $1.70M | $83.8K | 0.08% | -$1.62M |
| Immix Biopharma, Inc.(IMMX) | 25,000 | 35,000 | +10,000 | $51.8K | $73.2K | 0.07% | +$21.4K |
| Aclaris Therapeutics, Inc.(ACRS) | 32,700 | 32,700 | 0 | $46.4K | $62.1K | 0.06% | +$15.7K |
| PMV Pharmaceuticals, Inc.(PMVP) | 35,000 | 35,000 | 0 | $37.1K | $49.0K | 0.05% | +$11.9K |
| 4dmoleculartherapeuticsin | 12,000 | 0 | -12,000 | $44.5K | $0 | — | -$44.5K |
| Arvinas, Inc.(ARVN) | 500,000 | 0 | -500,000 | $3.68M | $0 | — | -$3.68M |
| Kiora Pharmaceuticals, Inc.(KPRX) | 122,223 | 0 | -122,223 | $352.0K | $0 | — | -$352.0K |
| Liquidia CorporationCOMNEW(LQDA) | 239,260 | 0 | -239,260 | $2.98M | $0 | — | -$2.98M |
| Nextcureinc | 45,000 | 0 | -45,000 | $20.7K | $0 | — | -$20.7K |
| Perspective Therapeutics, Inc.COMNEW(CATX) | 500,000 | 0 | -500,000 | $1.72M | $0 | — | -$1.72M |
| Scpharmaceuticalsinc | 917,668 | 0 | -917,668 | $3.50M | $0 | — | -$3.50M |
| Upstream Bio, Inc.(UPB) | 107,000 | 0 | -107,000 | $1.17M | $0 | — | -$1.17M |
| VeronapharmaplcSPONSOREDADS | 95,000 | 0 | -95,000 | $8.99M | $0 | — | -$8.99M |
| Yarrow Bioscience Inc(YARW) | 30,000 | 0 | -30,000 | $49.5K | $0 | — | -$49.5K |
| Zevra Therapeutics, Inc.COMNEW(ZVRA) | 715,000 | 0 | -715,000 | $6.30M | $0 | — | -$6.30M |